ALLO vs ETR · rev $22.0K vs P/E 28, rev $12.95B
Allogene Therapeutics Inc (ALLO) versus Entergy Corporation (ETR) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
ALLO currently screens at market cap $258.1M. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Not investment advice. Open the ALLO and ETR stock pages for the full models.
Not investment advice.